A prospective, interventional, single-arm clinical trial to evaluate the efficacy and safety of Ayurveda therapy protocol in the management of mild to moderate COVID-19 patients and its post complications

Pankajakasthuri herbal research foundation0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients tested positive for Covid-19 using RTPCR.
•2. Willing and able to provide written informed consent prior to performing study procedures by the subject or legal guardian.

•1. Subject or Authorized Representative is unable to provide informed consent.
•2. Subject is pregnant or breastfeeding ladies.
•3. Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital.
•4. Intra-thoracic or intra-abdominal surgery within the 12 hours prior to consent, or ongoing impairment of hemostasis as a result of one of these procedures.
•5. A history of head trauma, spinal trauma, or other acute trauma with an increased risk of bleeding.
•6. Cerebral Vascular Accident (CVA) or Intracerebral
•Arteriovenous Malformation (AVM), cerebral aneurysm, or mass
•lesions of the central nervous system or melena, hematemesis.
•7. Inability to take oral medication
•8. Prolonged QTc-interval in baseline ECG ( >500 ms)
•9. History of solid organ, allogeneic bone marrow, or stem cell transplantation.
•10. Severe renal failure characterized by chronic or acute need of hemodialysis, hemofiltration or peritoneal dialysis.
•11. Need of anticoagulants, antiplatelet agents, anti-thrombotics and thrombolytics during the treatment period.
•12. Participation in another research study involving an investigational agent within 30 days prior to consent.

发起方

Pankajakasthuri herbal research foundation